Cargando…

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study

SIMPLE SUMMARY: In this study, based on the results of chemotherapy or poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) maintenance in other tumors, we explore whether olaparib, a PARP inhibitor, could be useful in terms of prolonging radiographic progression of the disease in patients with meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juan Fita, María José, Anido Herranz, Urbano, Mendez-Vidal, María José, Gironés-Sarrió, Regina, Muñoz-Langa, José, Sepúlveda-Sánchez, Juan, Mellado, Begoña, Alvarez-Fernandez, Carlos, Heras López, Lucía, López-Guerrero, José Antonio, García-Casado, Zaida, Calatrava, Ana, Ángel Climent, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649956/ https://www.ncbi.nlm.nih.gov/pubmed/37958398 http://dx.doi.org/10.3390/cancers15215223

Ejemplares similares

Fantasmas del oriente, de Imanol Caneyada
por: Hernández, Héctor Justino
Publicado: (2022)

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023)

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group
por: Rubio-Briones, José, et al.
Publicado: (2021)

Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group
por: González-del-Alba, Aránzazu, et al.
Publicado: (2022)

SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
por: Valderrama, Begoña P., et al.
Publicado: (2022)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report
por: Ruiz-Bañobre, Juan, et al.
Publicado: (2016)

Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group
por: Gómez Caamaño, Antonio, et al.
Publicado: (2021)

1572P The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
por: Duran, M.A. Climent, et al.
Publicado: (2021)

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
por: Pereira-Veiga, Thais, et al.
Publicado: (2021)

Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE
por: Puente, Javier, et al.
Publicado: (2020)

A case of hand-foot syndrome with olaparib
por: da Costa, Rafael Everton Assunção Ribeiro, et al.
Publicado: (2022)

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting
por: Garrido Siles, Marga, et al.
Publicado: (2022)

Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
por: Quiñonero, Francisco, et al.
Publicado: (2023)

Adjuvant treatment in lung cancer
por: Valladares, Begoña Taboada, et al.
Publicado: (2021)

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
por: Grande, E., et al.
Publicado: (2022)

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
por: Poveda, Andres, et al.
Publicado: (2021)

Unusual Case of Superior Vena Cava Syndrome Caused by Intravascular Thyroid Metastasis
por: Varela Pose, Vanesa, et al.
Publicado: (2017)

Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
por: Poveda, Andres, et al.
Publicado: (2022)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Psychological Coping with Job Loss. Empirical Study to Contribute to the Development of Unemployed People
por: Navarro-Abal, Yolanda, et al.
Publicado: (2018)

What Does Work Signify for Those in Search of Labor? Meaning of Work for the Unemployed Who Attend an Employee Orientation Program
por: Navarro-Abal, Yolanda, et al.
Publicado: (2018)

Organisational Justice, Burnout, and Engagement in University Students: A Comparison between Stressful Aspects of Labour and University Organisation
por: Navarro-Abal, Yolanda, et al.
Publicado: (2018)

Healthcare students’ personality traits and competence-based learning methodologies
por: López-López, María José, et al.
Publicado: (2020)

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
por: Orta, Manuel Luis, et al.
Publicado: (2014)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients
por: Sarrió, Regina Gironés, et al.
Publicado: (2021)

Engagement, Passion and Meaning of Work as Modulating Variables in Nursing: A Theoretical Analysis
por: Gómez-Salgado, Juan, et al.
Publicado: (2019)

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Olaparib in the management of ovarian cancer
por: Bixel, Kristin, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Olaparib: Transcending mutational barriers
por: Chandna, Abhishek
Publicado: (2019)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib
por: Gong, Lifeng, et al.
Publicado: (2022)

Grieving for Job Loss and Its Relation to the Employability of Older Jobseekers
por: Climent-Rodríguez, José Antonio, et al.
Publicado: (2019)

Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
por: Wu, Min, et al.
Publicado: (2018)

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
por: Garcia-Casado, Zaida, et al.
Publicado: (2010)

Neuroprotective Role of Liver Growth Factor “LGF” in an Experimental Model of Cerebellar Ataxia
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2014)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
por: León-Mateos, Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kfdrr3efqf26g9gj4kpq1fprr1